You are here

MAXYGEN, INC.

Company Information
Address
MAXYGEN, INC. 515 GALVESTON DR
REDWOOD CITY, CA 94063 4720
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Novel Vaccine Immunogens for Pandemic H5 Influenza

    Amount: $599,983.00

    DESCRIPTION (provided by applicant): Influenza pandemics occur when an abrupt change in the composition of the circulating viruses results in a strain to which individuals have little or no immunity. ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  2. Novel gp41 Immunogens for HIV-1 Vaccines

    Amount: $215,504.00

    DESCRIPTION (provided by applicant): Clinical trials have shown that HIV-1 infection cannot be prevented by immunization with naturally occurring viral envelope (Env) proteins. However, it is clear t ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  3. Novel HIV-1 Envelope Proteins Based on Consensus Sequences

    Amount: $240,746.00

    DESCRIPTION (provided by applicant): The HIV-1 epidemic has resulted in ~5 million new infections in 2004 for a total of 40 million people living with HIV/AIDS. A vaccine that can protect against viru ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  4. Vaccines for Eastern and Western Equine Encephalitis Viruses

    Amount: $995,360.00

    DESCRIPTION (provided by applicant): Venezuelan, eastern, and western equine encephalitis viruses (VEEV, EEEV, WEEV respectively) are arthropod-borne alphaviruses that cause periodic epizootics in the ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  5. Creation of Stable Cleaved Trimers of the HIV-1 Envelope Protein

    Amount: $240,443.00

    DESCRIPTION (provided by applicant): The HIV-1 epidemic has resulted in ~5 million new infections in 2004 for a total of 40 million people living with HIV/AIDS. Clinical trials have shown that HIV-1 i ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  6. Glycosylation Variants of HIV-1 Envelope

    Amount: $299,284.00

    DESCRIPTION (provided by applicant): The HIV-1 epidemic has resulted in approximately 5 million new infections in 2004 for a total of 40 million people living with HIV/AIDS. A preventative vaccine for ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government